{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["7f2e2dfd-2bcd-41d9-911d-27632165474e", "Q3", 298012, "REINECKE STRATEGIC SOLUTIONS, INC.", 179856, "PHARMAVITE LLC", 2024, "third_quarter", "2024-10-09T13:03:34-04:00", 40000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/7f2e2dfd-2bcd-41d9-911d-27632165474e/\", \"filing_uuid\": \"7f2e2dfd-2bcd-41d9-911d-27632165474e\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2024, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/7f2e2dfd-2bcd-41d9-911d-27632165474e/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"40000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"PETER REINECKE\", \"dt_posted\": \"2024-10-09T13:03:34-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": \"United States of America\", \"registrant_address_1\": \"6107 Ridge Drive\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"Bethesda\", \"registrant_state\": \"MD\", \"registrant_zip\": \"20816\", \"registrant\": {\"id\": 298012, \"url\": \"https://lda.senate.gov/api/v1/registrants/298012/\", \"house_registrant_id\": 37584, \"name\": \"REINECKE STRATEGIC SOLUTIONS, INC.\", \"description\": \"Policy and communications consulting\", \"address_1\": \"6107 Ridge Drive\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"Bethesda\", \"state\": \"MD\", \"state_display\": \"Maryland\", \"zip\": \"20816\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"PETER REINECKE\", \"contact_telephone\": \"+1 703-785-6786\", \"dt_updated\": \"2026-01-12T10:56:07.165398-05:00\"}, \"client\": {\"id\": 179856, \"url\": \"https://lda.senate.gov/api/v1/clients/179856/\", \"client_id\": 63, \"name\": \"PHARMAVITE LLC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": null, \"state\": \"CA\", \"state_display\": \"California\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"CA\", \"ppb_state_display\": \"California\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2013-11-25\"}, \"lobbying_activities\": [{\"general_issue_code\": \"FOO\", \"general_issue_code_display\": \"Food Industry (safety, labeling, etc.)\", \"description\": \"Improving the regulation of dietary supplements. H.R. 9029/S.4690 Agriculture and Related Agencies Appropriations Act for FY25 Specifically for adequate funding for regulation of dietary supplements. H.R. 4794/S.3177, giving consumers with HSA or FSA the ability to use account funding for the purchase of certain dietary supplements. S.4287, Dietary Supplement Listing Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 9270, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"PETER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"REINECKE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"LD, CoS, Sr. Advisor, Sen. Harkin\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"H.R. 9029/S.4690, Agriculture and Related Agencies Appropriations Act for FY25 specifically for adequate funding for regulation of dietary supplements. H.R. 9020/S.4942FY 2025 Appropriations for Department of HHS, specifically for adequate research and education about menopause and women's health.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 9270, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"PETER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"REINECKE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"LD, CoS, Senior Advisor, Sen. Tom Harkin\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"H.R. 4794/S.3177 giving consumers with HSA or FSA the ability to use account funding for the purchase of certain dietary supplements.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 9270, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"PETER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"REINECKE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"LD, CoS, Sr. Advisor, Sen. Tom Harkin\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"H.R. 9027/S.4690 Agriculture and Related Agencies Appropriations Act for FY25,specifically for adequate funding for regulation of dietary supplements. FY 2025 Appropriations for Department of HHS (H.R. 9020/S.4942)specifically for adequate research and education about menopause and women's health.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 9270, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"PETER\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"REINECKE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"CoS, LD, Senior Advisor Senator Tom Harkin\", \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "MD", "US", 37584, "CA", "CA", "US", "US", null, 0, 0, 1954629, null, "normalized_name_state", 0.9]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["7f2e2dfd-2bcd-41d9-911d-27632165474e"], "units": {}, "query_ms": 1.1167130433022976, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}